<DOC>
	<DOC>NCT00178932</DOC>
	<brief_summary>The goals of this study are to replicate previous findings of genetic predictors of response to clozapine and other antipsychotic drugs.</brief_summary>
	<brief_title>Improving Outcome in Schizophrenia Through Identification of Genetic Risk Factors</brief_title>
	<detailed_description />
	<mesh_term>Disease</mesh_term>
	<mesh_term>Schizophrenia</mesh_term>
	<mesh_term>Bipolar Disorder</mesh_term>
	<mesh_term>Depressive Disorder, Major</mesh_term>
	<mesh_term>Psychotic Disorders</mesh_term>
	<criteria>Patients with the diagnoses of schizophrenia or schizoaffective disorder, and bipolar disorder or major depression with psychotic features, or volunteers with no history of a psychotic disorder. Patients with DSMIV diagnoses other than schizophrenia or schizoaffective disorder, and bipolar disorder or major depression with psychotic features.</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>November 2010</verification_date>
</DOC>